510(k)
K062575: MODIFICATION TO: ACCUSIGN RC DOA 10 (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP
FDA 510(k) · Princeton BioMeditech Corp. · decided Nov 26, 2007
Key facts
| 510(k) number | K062575 |
|---|---|
| Device name | MODIFICATION TO: ACCUSIGN RC DOA 10 (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP |
| Applicant | Princeton BioMeditech Corp. |
| Product code | LAG |
| Subsequent product codes | DIO, DIS, DJG, DJR, DKE, DKZ, JXM, LCM, LFI |
| Date received | Aug 31, 2006 |
| Decision date | Nov 26, 2007 |
| Decision | Substantially equivalent (SESE) |
| Submission type | Traditional |
| Review panel | Clinical Toxicology |
| Medical specialty | Clinical Toxicology |
At a glance
- None MAUDE adverse event reports
- None Recall events
- None UDI device identifiers (GUDID)
- 1–9 Predicate devices cited
- None Later submissions citing this device
- 1–9 510(k)s with this product code
- Yes 510(k) summary on file
- No 510(k) statement on file
- Not listed On the FDA AI-enabled device list
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
Reading a 510(k)
- Decision
- SESE means the FDA found the device substantially equivalent to its predicate, so it may be marketed in the United States.
- Predicates
- Each clearance cites one or more legally marketed devices; the chain of predicates shows where a technology came from.
- Product code
- The three-letter code sets the device type, class and regulation, and groups competing clearances.
- Summary or statement
- Applicants file either a 510(k) summary of the safety and effectiveness information or a statement that it is available on request.
About 510(k) premarket notifications
A 510(k) is a premarket submission made to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device.
Source: U.S. Food and Drug Administration (FDA), 510(k) Premarket Notification database · Source date: